Acetylcholine is a chemical messenger that nerve cells use to pass signals, and some memory and thinking problems in Alzheimer's disease are thought to come from too little of it. Donepezil blocks acetylcholinesterase, the enzyme that normally breaks acetylcholine down. With the enzyme blocked, more acetylcholine stays available, which is believed to strengthen signaling between nerve cells. The block is reversible rather than permanent.
It leaves the body slowly, taking about 70 hours to clear half of it, so levels build up and settle only after about 15 days. The liver breaks much of it down, and part of it leaves unchanged in the urine. The same rise in acetylcholine affects the gut, heart, and stomach, which explains its main risks: nausea, vomiting, and diarrhea, a slow heartbeat or fainting, and more stomach acid that can raise the chance of ulcers and bleeding. Stomach upset is most likely when starting or raising the dose and often fades with time.